Abstract
The Epstein-Barr virus (EBV) is a lymphotropic herpes virus with oncogenetic properties which can lead to the development of lymphomas such as Burkitt's lymphoma (BL), Hodgkin's lymphoma (HL), or post-transplant lymphoma. This review discusses our current understanding of lymphomagenesis in relation to EBV and the potential for targeted therapies.
| Original language | English |
|---|---|
| Pages (from-to) | 348-353 |
| Number of pages | 6 |
| Journal | Cancer Treatment Reviews |
| Volume | 36 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Jun 2010 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Childhood
- EBV
- Herpes virus
- Lymphoma
- Therapy
Fingerprint
Dive into the research topics of 'The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver